Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...

Pharmacokinetics in Pediatric Patients: Drug Distribution

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...

Healthcare Associated Infections II: Preventive Measures

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

Pharmacokinetics in Pediatric Patients: Drug Metabolism

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...

Drug Dosing: Infants and Children

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Multimodal characterization of variation in neuronal types in the mouse basal ganglia.

bioRxiv : the preprint server for biology·2026

Same author

Connecting single-cell transcriptomes to projectomes in the mouse visual cortex.

Nature·2026

Same author

Anticoagulation Changes and Biochemical Signals Preceding Hospital-Acquired Infections in Pediatric Extracorporeal Support.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026

Same author

Morphoelectric Diversity and Specialization of Neuronal Cell Types in the Primate Striatum.

bioRxiv : the preprint server for biology·2026

Same author

Topographic structure and function of locus coeruleus norepinephrine neurons.

bioRxiv : the preprint server for biology·2026

Same author

Prophylactic Levofloxacin Use in Oncology and Hematopoietic Stem Cell Transplants for Children Under 2 Years of Age.

Journal of pediatric hematology/oncology·2026

Search research articles

Related Experiment Video

Updated: Oct 25, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Considerations for implementation: Pediatric outpatient antimicrobial stewardship program.

Elizabeth A Monsees¹, Alaina N Burns¹, Brian R Lee¹

¹Children's Mercy Kansas City, Kansas City, MO; University of Missouri Kansas City, Kansas City, MO.

American Journal of Infection Control

|August 6, 2021

Summary

This summary is machine-generated.

Most antibiotic use occurs in outpatient settings lacking infectious disease specialists. This study proposes strategies for adult providers to implement antimicrobial stewardship (AS) in pediatric outpatient care, improving antibiotic use and quality improvement.

Keywords:

Antibiotic stewardship Children Community Framework

More Related Videos

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

Quantifying the Effects of Antimicrobials on In vitro Biofilm Architecture using COMSTAT Software

Quantifying the Effects of Antimicrobials on In vitro Biofilm Architecture using COMSTAT Software

Published on: December 14, 2020

Related Experiment Videos

Last Updated: Oct 25, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

Quantifying the Effects of Antimicrobials on In vitro Biofilm Architecture using COMSTAT Software

Quantifying the Effects of Antimicrobials on In vitro Biofilm Architecture using COMSTAT Software

Published on: December 14, 2020

Area of Science:

Infectious Diseases
Public Health
Pediatrics

Background:

Formal antimicrobial stewardship (AS) programs are common in acute care settings.
The majority of antibiotic prescriptions are issued in outpatient settings.
Outpatient settings often lack access to infectious diseases specialists, particularly for pediatric care.

Purpose of the Study:

To propose considerations for adult providers and infection preventionists.
To guide the incorporation of outpatient AS elements into community settings.
To support quality improvement initiatives for pediatric antibiotic use.

Main Methods:

Review of current antimicrobial stewardship practices.
Analysis of antibiotic prescribing patterns in pediatric outpatient settings.
Development of actionable recommendations for providers.

Main Results:

Identified gaps in pediatric outpatient antimicrobial stewardship.
Highlighted the need for tailored AS strategies for nonacademic settings.
Proposed three key considerations for implementation.

Conclusions:

Antimicrobial stewardship is crucial in outpatient pediatric settings.
Adult providers can play a key role in optimizing pediatric antibiotic use.
Quality improvement initiatives are essential for effective outpatient AS.